In line with findings from previous studies, gCIMP status of the tumor was associated with IDH1 mutation, lower tumor grade, histopathology of the tumor, lack of EGFR amplification, and strong p53 staining (indicative of mutation [23]) [9–11,27]. This evidence concerns the gene EGFR and neoplasm.